Form 4 Tracker
Schrodinger, Inc.
SDGR

32 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 1, 2026Jul 1 7:19 PMAklian Mannix Vartan
Proposed Sale
1,136$16.68$18.9K

View →

May 1, 2026May 1 7:18 PMHerman Jenny
Proposed Sale
1,957$12.26$24.0K

View →

Apr 17, 2026Apr 17 10:09 PMRamy FaridDirector, President & CEO
Sale
43,000$12.21$524.9K330,824(D)

View →

Apr 16, 2026Apr 17 10:09 PMRamy FaridDirector, President & CEO
Sale
43,000$12.33$530.2K330,824(D)

View →

Apr 16, 2026Apr 17 10:07 PMRachit JainEVP & CFO
Sale
844$12.75$10.8K51,752(D)

View →

Apr 16, 2026Apr 16 8:14 PMRAMY SAMIR FARID
Proposed Sale
86,000$12.40$1.1M

View →

Apr 16, 2026Apr 16 7:10 PMJain Rachit
Proposed Sale
844$12.75$10.8K

View →

Mar 6, 2026Mar 6 10:29 PMJenny HermanCAO
Sale
608$12.84$7.8K34,804(D)

View →

Mar 5, 2026Mar 6 10:29 PMJenny HermanCAO
Sale
775$12.85$10.0K35,412(D)

View →

Mar 5, 2026Mar 6 10:29 PMRachit JainEVP & CFO
Sale
1,631$12.90$21.0K52,596(D)

View →

Mar 5, 2026Mar 6 10:28 PMYvonne TranEVP, CLO & CPO
Sale
1,094$12.90$14.1K52,683(D)

View →

Mar 5, 2026Mar 6 10:28 PMRamy FaridDirector, President & CEO
Sale
3,661$12.91$47.2K330,824(D)

View →

Mar 5, 2026Mar 6 10:27 PMKaren AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Sale
1,366$12.90$17.6K69,956(D)

View →

Mar 5, 2026Mar 6 10:26 PMKenneth Patrick LortonEVP, CTO & COO, Software
Sale
1,222$12.90$15.8K89,241(D)

View →

Mar 4, 2026Mar 6 10:26 PMRobert Lorne AbelEVP, Chief Scientific Officer, Platform
Sale
1,300$12.81$16.7K55,897(D)

View →

Mar 6, 2026Mar 6 8:18 PMHerman Jenny
Proposed Sale
608$12.84$7.8K

View →

Mar 5, 2026Mar 5 8:27 PMLorton Kenneth Patrick
Proposed Sale
1,222$12.90$15.8K

View →

Mar 5, 2026Mar 5 8:16 PMTran Yvonne
Proposed Sale
1,094$12.89$14.1K

View →

Mar 5, 2026Mar 5 8:16 PMHerman Jenny
Proposed Sale
775$12.85$10.0K

View →

Mar 5, 2026Mar 5 8:14 PMFarid Ramy
Proposed Sale
3,661$12.91$47.2K

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 22, 2026Jun 23 9:01 PMArun OberoiDirector
Grant/Award
13,313$15.2313,313(D)

View →

Jun 22, 2026Jun 23 8:38 PMJeffrey ChodakewitzDirector
Grant/Award
13,313$15.2313,313(D)

View →

Jun 22, 2026Jun 23 8:38 PMRichard FriesnerDirector
Grant/Award
13,313$15.2313,313(D)

View →

Jun 22, 2026Jun 23 8:37 PMGary L GinsbergDirector
Grant/Award
13,313$15.2313,313(D)

View →

Jun 22, 2026Jun 23 8:33 PMRosana Kapeller-LibermannDirector
Grant/Award
13,313$15.2313,313(D)

View →

Jun 22, 2026Jun 23 8:32 PMMichael LyntonDirector
Grant/Award
13,313$15.2313,313(D)

View →

Jun 22, 2026Jun 23 8:29 PMGary SenderDirector
Grant/Award
13,313$15.2313,313(D)

View →

Jun 22, 2026Jun 23 8:28 PMNancy ThornberryDirector
Grant/Award
13,313$15.2313,313(D)

View →

Jun 22, 2026Jun 23 8:28 PMKralingen Bridget A VanDirector
Grant/Award
13,313$15.2313,313(D)

View →

Apr 17, 2026Apr 17 10:09 PMRamy FaridDirector, President & CEO
Option Exercise
117,527$3.070(D)

View →

Apr 16, 2026Apr 17 10:09 PMRamy FaridDirector, President & CEO
Option Exercise
43,000$3.07117,527(D)

View →

Mar 2, 2026Mar 3 9:34 PMRichard FriesnerDirector
Option Exercise
160,527$3.070(D)

View →

Mar 2, 2026Mar 3 9:34 PMRamy FaridDirector, President & CEO
Grant/Award
112,500$12.15112,500(D)

View →

Mar 2, 2026Mar 3 9:33 PMRachit JainEVP & CFO
Grant/Award
34,250$12.1534,250(D)

View →

Mar 2, 2026Mar 3 9:33 PMYvonne TranEVP, CLO & CPO
Grant/Award
34,250$12.1534,250(D)

View →

Mar 2, 2026Mar 3 9:32 PMKenneth Patrick LortonEVP, CTO & COO, Software
Grant/Award
34,250$12.1534,250(D)

View →

Mar 2, 2026Mar 3 9:32 PMJenny HermanCAO
Grant/Award
8,220$12.158,220(D)

View →

Mar 2, 2026Mar 3 9:31 PMKaren AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Grant/Award
48,500$12.1548,500(D)

View →

Mar 2, 2026Mar 3 9:31 PMMannix Vartan AklianEVP, Chief Commercial Officer, Global Head of Software Sales & Marketing
Grant/Award
34,250$12.1534,250(D)

View →

Mar 2, 2026Mar 3 9:30 PMRobert Lorne AbelEVP, Chief Scientific Officer, Platform
Grant/Award
34,250$12.1534,250(D)

View →